计算溶液所需的质量、体积或浓度。
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
Moligand™ 级 提供 ≥98% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
2-8°C储存。低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Sudoxicam 是一种可逆的口服活性的 COX 拮抗剂,是烯醇-羧酰胺类的非甾体抗炎剂 (NSAID)。Sudoxicam 具有有效的抗炎,抗浮肿和退热作用。
Sudoxicam and Meloxicam are nonsteroidal, anti-inflammatory drugs (NSAIDs) from the enol-carboxamide class.
Biological activity:
Sudoxicam is a reversible and orally active COX antagonist and a non-steroidal anti-inflammatory drug (NSAID) from the enol-carboxamide class. Sudoxicam has potent anti-inflammatory, anti-edema and antipyretic activity
In vitro research:
Sudoxicam demonstrates NADPH-dependent covalent binding to human liver microsomes. With addition of glutathione (GSH) in microsomal incubations, about half of the covalent incorporation of Sudoxicam is blocked by addition of GSH.
Metabolite identification studies on [14C]-Sudoxicam in NADPH-supplemented human liver microsomes indicated that the primary route of metabolism involved a P450-mediated thiazole ring scission to the corresponding acylthiourea metabolite (S3), a well-established pro-toxin
In vitro, Sudoxicam underwent the oxidative thiazole-open biotransformation, resulting in the formation of an acylthiourea and the subsequent hydroxylated metabolite
In vivo research:
Sudoxicam (1-10 mg/kg; oral administration; daily; for 7 days; rats) treatment effective reduces plasma inflammation units, reduces the swelling of inflamed hind-paws and restores toward normal the daily gain in body weight
In the intact rat, Sudoxicam significantly inhibited edema formation at doses as low as 0.1 mg/kg, p.o
Sudoxicam inhibits the erythema caused by ultraviolet irradiation in the guinea pig. Sudoxicam (3.3 mg/kg, i.p.) is capable of counteracting the pyrexia induced by the intraperitoneal injection of typhoid/paratyphoid vaccine in rats, maintaining body temperature about that of uninjected control rats
The plasma half-life of Sudoxicam ranged between 8 hours (monkey), 13 hours (rat), and 60 hours (dog)
Animal Model: Rats injected with ,i>M. butyrieum
Dosage:1 mg/kg, 3.3 mg/kg, 10 mg/kg
Administration:Oral administration; daily; for 7 days
Result:Were both effective in reducing plasma inflammation units, in reducing the swelling of inflamed hind-paws.
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机杂环化合物 |
| 类(Class) | 苯并噻嗪类 |
| 亚类(Subclass) | 暂无 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 苯并噻嗪类 |
| 其他上位类(Alternative Parents) | α氨基酸及其衍生物 N-芳基酰胺 有机磺酰胺 苯类化合物 1,2-噻嗪类 乙烯基酸 噻唑类 杂芳族化合物 仲羧酸酰胺 氮杂环化合物 有机光子化合物 有机氧化物 碳氢化合物衍生物 羰基化合物 |
| 分子骨架(Molecular Framework) | 芳香族杂多环化合物 |
| 取代基(Substituents) | α-氨基酸或其衍生物 - 芳香族杂多环化合物 - 氮杂环 - 吡唑 - 苯基化合物 - 苯并噻嗪 - 羰基 - 羧酰胺基 - 羧酸衍生物 - 杂芳香族化合物 - 烃衍生物 - N-芳基酰胺 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机磺酸或其衍生物 - 有机氮化合物 - 有机氧化合物 - 有机氮化合物 - 有机硫酰胺 - 有机磺酸或其衍生物 - 邻噻嗪 - 醛基 - 噻唑 - 乙烯基羧酸 |
| 描述(Description) | 该化合物属于苯并噻嗪类有机化合物。这类化合物由苯环与噻嗪环(含四个碳原子、一个氮原子和一个硫原子的六元环)共轭组成。 |
| 外部描述符(External Descriptors) | 暂无 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
H301: 吞咽会中毒
P264: 处理后要彻底洗手。
P270: 使用本产品时,请勿进食、饮水或吸烟。